Literature DB >> 2982734

Transferrin receptor expression by stimulated cells in mixed lymphocyte culture.

M Salmon, P A Bacon, D P Symmons, K W Walton.   

Abstract

Transferrin receptor (TRFr) expression by cells in mixed lymphocyte culture increases steadily for the first 5 days, but then reaches a plateau. By the sixth day in culture, about 20% of viable cells express TRFr in two-way mixed lymphocyte reactions. This subpopulation of TRFr-positive cells represents the proliferating population; it is heterogeneous, containing T-cell blasts and smaller cells which are a mixture of T and non-T cells. A small group of non-T cells have phenotypic similarity to natural killer (NK) cells. T cells appear to divide earlier in the course of the response than non-T cells. The biphasic nature of this response and the slower non-T reactivity may be due to a secondary stimulation of non-T cells by factors released from activated T cells (such as interleukin-2).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982734      PMCID: PMC1453534     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

2.  The use of cytocentrifuge preparations for the demonstration of T cell surface antigens.

Authors:  M Salmon; P A Bacon; G D Johnson; L Walker; K W Walton
Journal:  J Immunol Methods       Date:  1984-02-10       Impact factor: 2.303

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Transferrin binding by mitogen-activated human peripheral blood lymphocytes.

Authors:  G M Galbraith; J M Goust; S M Mercurio; R M Galbraith
Journal:  Clin Immunol Immunopathol       Date:  1980-08

7.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

8.  Characterisation of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis.

Authors:  S D Carter; P A Bacon; N D Hall
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

9.  Demonstration of transferrin receptors on human placental trophoblast.

Authors:  G M Galbraith; R M Galbraith; A Temple; W P Faulk
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

10.  Transferrin and transferrin receptors in carcinoma of the breast.

Authors:  W P Faulk; B L Hsi; P J Stevens
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

View more
  9 in total

1.  A cellular deficiency in the rheumatoid one-way mixed lymphocyte reaction.

Authors:  M Salmon; P A Bacon
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

2.  Abnormal populations of activated lymphocytes in the rheumatoid one-way MLR.

Authors:  M Salmon; P A Bacon
Journal:  Agents Actions       Date:  1986-12

3.  Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.

Authors:  M Salmon; P A Bacon; D P Symmons; A D Blann
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  T cell survival and function requires the c-Abl tyrosine kinase.

Authors:  Isabelle Silberman; Ronit Vogt Sionov; Valentina Zuckerman; Sue Haupt; Zehavit Goldberg; Andreas Strasser; Zami S Ben-Sasson; Michal Baniyash; Anthony J Koleske; Ygal Haupt
Journal:  Cell Cycle       Date:  2008-12-23       Impact factor: 4.534

7.  Natural killer cells in peripheral blood and the mixed lymphocyte response: interaction with the transferrin receptor.

Authors:  M Salmon; P A Bacon; S P Young
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

8.  Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications.

Authors:  G D Kitas; M Salmon; M Farr; J S Gaston; P A Bacon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

9.  Skin regeneration in deep second-degree scald injuries either by infusion pumping or topical application of recombinant human erythropoietin gel.

Authors:  Priya Giri; Sabine Ebert; Ulf-Dietrich Braumann; Mathias Kremer; Shibashish Giri; Hans-Günther Machens; Augustinus Bader
Journal:  Drug Des Devel Ther       Date:  2015-05-11       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.